Pandemic preparedness: developing vaccines and therapeutic antibodies for COVID-19

Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/41246

Registro completo de metadados

Campo DC	Valor	Idioma
dc.creator	Sempowski, Gregory D.	-
dc.creator	Saunders, Kevin O.	-
dc.creator	Acharya, Priyamvada	-
dc.creator	Wiehe, Kevin J.	-
dc.creator	Haynes, Barton F.	-
dc.date.accessioned	2020-05-27T13:15:15Z	-
dc.date.available	2020-05-27T13:15:15Z	-
dc.date.issued	2020	-
dc.identifier.citation	SEMPOWSKI, G. D. et al. Pandemic preparedness: developing vaccines and therapeutic antibodies for COVID-19. Cell, [S.l.], 2020. No prelo.	pt_BR
dc.identifier.uri	http://www.sciencedirect.com/science/article/pii/S0092867420306747	pt_BR
dc.identifier.uri	http://repositorio.ufla.br/jspui/handle/1/41246	-
dc.description.abstract	The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic and private partnerships working together to rapidly develop vaccine and antibody countermeasures. Many of the technologies being used are derived from prior government-academic partnerships for response to other emerging infections.	pt_BR
dc.language	en_US	pt_BR
dc.publisher	Elsevier	pt_BR
dc.rights	restrictAccess	pt_BR
dc.source	Cell	pt_BR
dc.subject	COVID-19 - Vaccine	pt_BR
dc.subject	Monoclonal antibodies (mAb)	pt_BR
dc.title	Pandemic preparedness: developing vaccines and therapeutic antibodies for COVID-19	pt_BR
dc.type	Artigo	pt_BR
Aparece nas coleções:	FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:

Não existem arquivos associados a este item.